SunWay Biotech Co (ROCO:1271) Research & Development: NT$43.5 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1271 SunWay Biotech Co Ltd ROCO:1271
90 GF Score
Price NT$61.00
GF Value NT$71.11
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is SunWay Biotech Co Research & Development?

SunWay Biotech Co ROCO:1271 -4.39% 90 Research & Development is NT$43.5 Mil as of Dec. 2025. GuruFocus rates ROCO:1271 with a GF Score™ of 90/100 and a GF Value™ of NT$71.11 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. SunWay Biotech Co's Research & Development for the six months ended in Dec. 2025 was NT$19.2 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$43.5 Mil.

SunWay Biotech Co  (ROCO:1271) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

SunWay Biotech Co Research & Development Related Terms

SunWay Biotech Co Research & Development Historical Data

* Premium members only.

The historical data trend for SunWay Biotech Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SunWay Biotech Co Research & Development Chart

SunWay Biotech Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 43.38 0.00 6.21 54.02 43.53

SunWay Biotech Co Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.21 28.57 25.45 24.30 19.24
ROCO:1271
90GF Score
SunWay Biotech Co Ltd ROCO:1271
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SunWay Biotech Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$43.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$43.5 Mil mean?
SunWay Biotech Co (ROCO:1271) has a Research & Development of NT$43.5 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on SunWay Biotech Co and its competitors.
Is SunWay Biotech Co's Research & Development too high?
SunWay Biotech Co's current Research & Development is NT$43.5 Mil. Overall, SunWay Biotech Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SunWay Biotech Co's Research & Development compare to KHC and GIS?
SunWay Biotech Co's Research & Development of NT$43.5 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on SunWay Biotech Co and its competitors. SunWay Biotech Co's current Research & Development is NT$43.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SunWay Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, SunWay Biotech Co (ROCO:1271) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$71.11, compared to a current price of NT$61.00 — trading 14.2% below its estimated fair value. The current Research & Development is NT$43.5 Mil. SunWay Biotech Co's overall GF Score™ is 90/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For SunWay Biotech Co (ROCO:1271), the current Research & Development is NT$43.5 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SunWay Biotech Co (ROCO:1271) Overvalued in 2026?

Based on GuruFocus' analysis, SunWay Biotech Co stock appears to be undervalued. The current stock price of NT$61.00 is trading 14.2% below its estimated GF Value™ of NT$71.11. GuruFocus considers SunWay Biotech Co to be Modestly Undervalued.

Key valuation signals for ROCO:1271:

  • Research & Development: NT$43.5 Mil
  • GF Value™: NT$71.11 vs. price of NT$61.00 (14.2% below fair value)
  • GF Score™: 90/100 with 7 warning signs

No single metric tells the full story. See the ROCO:1271 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SunWay Biotech Co Business Description

Address No. 139, Xing’ai Road, Neihu District, Taipei, TWN, 11494
SunWay Biotech Co Ltd is engaged in the research, design and manufacturing of Monascus purpureus NTU 568, Lactobacillus paracasei subsp, paracasei NTU 101, and the related products.
90GF Score

Get the complete analysis for ROCO:1271

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$61.00
Price
NT$71.11
GF Value